These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Relationship between EBV infection and expression of cellular proteins c-Myc, Bcl-2, and Bax in gastric carcinomas. Lima MA; Ferreira MV; Barros MA; Pardini MI; Ferrasi AC; Mota RM; Rabenhorst SH Diagn Mol Pathol; 2008 Jun; 17(2):82-9. PubMed ID: 18382371 [TBL] [Abstract][Full Text] [Related]
4. Flow cytometric analysis of c-myc oncoprotein in non-small-cell lung carcinoma: comparison with immunohistochemical results. De Santis L; Mangili F; Sassi I; Di Rocco M; Rossi C; Cantaboni A Anal Cell Pathol; 1995 Apr; 8(3):247-57. PubMed ID: 7547497 [TBL] [Abstract][Full Text] [Related]
5. Modulation of c-myc oncogene expression by phorbol ester and interferon-gamma: appraisal by flow cytometry. Mohamed AN; Nakeff A; Mohammad RM; KuKuruga M; al-Katib A Oncogene; 1988 Oct; 3(4):429-35. PubMed ID: 3152600 [TBL] [Abstract][Full Text] [Related]
6. The expression of EGF receptors, EGF-like factors and c-myc in ovarian and cervical carcinomas and their potential clinical significance. Kohler M; Janz I; Wintzer HO; Wagner E; Bauknecht T Anticancer Res; 1989; 9(6):1537-47. PubMed ID: 2697181 [TBL] [Abstract][Full Text] [Related]
7. Modified true-color computer-assisted image analysis versus subjective scoring of estrogen receptor expression in breast cancer: a comparison. Kohlberger PD; Breitenecker F; Kaider A; Lösch A; Gitsch G; Breitenecker G; Kieback DG Anticancer Res; 1999; 19(3B):2189-93. PubMed ID: 10472329 [TBL] [Abstract][Full Text] [Related]
8. In situ hybridization for the detection of low copy numbers of c-abl oncogene mRNA in lymphoma cells: technical approach and comparison with results with anti-oncoprotein antibodies. Greil R; Fasching B; Huber H Lab Invest; 1989 Apr; 60(4):574-82. PubMed ID: 2651801 [TBL] [Abstract][Full Text] [Related]
9. Expression of the c-myc protooncogene product in cells infected with the hepatitis delta virus. Tappero G; Natoli G; Anfossi G; Rosina F; Negro F; Smedile A; Bonino F; Angeli A; Purcell RH; Rizzetto M Hepatology; 1994 Nov; 20(5):1109-14. PubMed ID: 7523269 [TBL] [Abstract][Full Text] [Related]
10. Ultrastructural localization and fluctuation in the level of the proliferating cell nuclear antigen and myc oncoproteins in synchronized neuroblastoma cells. Gazitt Y; Erdos GW; Cohen RJ Cancer Res; 1993 Apr; 53(8):1899-905. PubMed ID: 8096797 [TBL] [Abstract][Full Text] [Related]
11. Distribution of c-myc oncoprotein in healthy and atherosclerotic human carotid arteries. Marin ML; Gordon RE; Veith FJ; Tulchin N; Panetta TF J Vasc Surg; 1993 Aug; 18(2):170-6; discussion 176-7. PubMed ID: 8350425 [TBL] [Abstract][Full Text] [Related]
12. Correlation of c-myc expression with nuclear pleomorphism in human renal cell carcinoma. Kinouchi T; Saiki S; Naoe T; Uenaka A; Kotake T; Shiku H; Nakayama E Cancer Res; 1989 Jul; 49(13):3627-30. PubMed ID: 2659164 [TBL] [Abstract][Full Text] [Related]
13. Association of c-myc overexpression and hyperproliferation with arsenite-induced malignant transformation. Chen H; Liu J; Zhao CQ; Diwan BA; Merrick BA; Waalkes MP Toxicol Appl Pharmacol; 2001 Sep; 175(3):260-8. PubMed ID: 11559025 [TBL] [Abstract][Full Text] [Related]
14. Correlation between c-myc protein expression and phases of the cell cycle in human colorectal carcinomas. Sato H; Tsuchiya A; Abe R Fukushima J Med Sci; 1995 Dec; 41(2):111-23. PubMed ID: 8823991 [TBL] [Abstract][Full Text] [Related]
15. Quantification of relative area of pS2 immunohistochemical staining and epithelial percentage in breast carcinomas: the effect of the latter on the interpretation of a cytosolic pS2 assay. Willemse F; Nap M; Eggink HF; Foekens JA; Henzen-Logmans SC; van Putten WL Mod Pathol; 1995 Jun; 8(5):521-5. PubMed ID: 7675771 [TBL] [Abstract][Full Text] [Related]
16. Use of the OM-11-906 monoclonal antibody for determining p62 c-myc expression by flow cytometry in relation to prognosis in colorectal cancer. Rowley S; Carpenter R; Newbold KM; Gearty J; Keighley MR; Donovan IA; Neoptolemos JP Eur J Surg Oncol; 1991 Aug; 17(4):370-8. PubMed ID: 1874294 [TBL] [Abstract][Full Text] [Related]
17. Fluctuations and ultrastructural localization of oncoproteins and cell cycle regulatory proteins during growth and apoptosis of synchronized AGF cells. Gazitt Y; Erdos GW Cancer Res; 1994 Feb; 54(4):950-6. PubMed ID: 7906198 [TBL] [Abstract][Full Text] [Related]
18. Phosphotyrosine, p62 c-myc and p21 c-Ha-ras proteins in colonic epithelium of normal and dimethylhydrazine-treated rats: an immunohistochemical analysis. Schwartz B; Benharroch D; Prinsloo I; Cagnano E; Lamprecht SA Anticancer Res; 1995; 15(1):211-8. PubMed ID: 7537485 [TBL] [Abstract][Full Text] [Related]
19. Expression of ras and c-myc oncoproteins and hepatitis B surface antigen in human liver disease. Tiniakos D; Spandidos DA; Yiagnisis M; Tiniakos G Hepatogastroenterology; 1993 Feb; 40(1):37-40. PubMed ID: 8462926 [TBL] [Abstract][Full Text] [Related]
20. Effect of curcumin on cell cycle progression and apoptosis in vascular smooth muscle cells. Chen HW; Huang HC Br J Pharmacol; 1998 Jul; 124(6):1029-40. PubMed ID: 9720770 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]